Evidence of BCR-ABL1-positive progenitor spread in blood during molecular recurrence after TKI discontinuation in chronic myeloid leukemia (CML)

Autor:	Ali G. Turhan, Jean-Henri Bourhis, Jean-Claude Chomel, Annelise Bennaceur-Griscelli, Nathalie Sorel, Patricia Hugues, Christophe Desterke
Rok vydání:	2020
Předmět:	Cancer Research medicine.drug_class business.industry Myeloid leukemia Hematology medicine.disease Fusion protein Tyrosine-kinase inhibitor respiratory tract diseases Discontinuation 03 medical and health sciences Bcr abl1 Leukemia Myelogenous 0302 clinical medicine Oncology hemic and lymphatic diseases 030220 oncology & carcinogenesis medicine Cancer research business 030215 immunology Progenitor
Zdroj:	Leukemia & Lymphoma. 61:1719-1723
ISSN:	1029-2403 1042-8194
DOI:	10.1080/10428194.2020.1734593
Popis:	Tyrosine kinase inhibitor (TKI) cessation strategies have shown both their great interest and their feasibility for selected patients with chronic myeloid leukemia (CML) [1]. It has been demonstrat...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::68518240e2f295419fdc3038fb83d01b https://doi.org/10.1080/10428194.2020.1734593 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.